Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Francioli

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
AIDS (London, England)|August 13, 2002
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA studyA Mocroft, R Brettle, O Kirk, et al.
Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.
Lancet (London, England)|March 27, 1999
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyB Ledergerber, M Egger, M Opravil, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
Critical Care Medicine|July 9, 1999
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patientsP Eggimann, P Francioli, J Bille, et al.
Annals of Internal Medicine|April 15, 1994
Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trialG Prod'hom, P Leuenberger, J Koerfer, et al.
JAMA|December 22, 1999
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort StudyB Ledergerber, M Egger, V Erard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2002
Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clonesD S Blanc, D Pittet, C Ruef, et al.
Lancet (London, England)|December 16, 2000
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyG Greub, B Ledergerber, M Battegay, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
AIDS (London, England)|August 13, 2002
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA studyA Mocroft, R Brettle, O Kirk, et al.
Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.
Lancet (London, England)|March 27, 1999
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyB Ledergerber, M Egger, M Opravil, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
Critical Care Medicine|July 9, 1999
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patientsP Eggimann, P Francioli, J Bille, et al.
Annals of Internal Medicine|April 15, 1994
Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trialG Prod'hom, P Leuenberger, J Koerfer, et al.
JAMA|December 22, 1999
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort StudyB Ledergerber, M Egger, V Erard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2002
Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clonesD S Blanc, D Pittet, C Ruef, et al.
Lancet (London, England)|December 16, 2000
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyG Greub, B Ledergerber, M Battegay, et al.
Pageof 17